MTOR and Abnormal renal physiology: The adverse events (AEs) leading to treatment discontinuation included gastrointestinal perforation, renal dysfunction, perianal abscess, diarrhea, hyponatremia and hoarseness due to axitinib, dermatitis, stomatitis, and skin rash due to mTOR inhibitors.